Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05777161 · ClinicalTrials.gov registry record · NA
A Trial of Parent-coached Exposure Therapy for Children With Anxiety Disorders and OCD
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT05777161: Completed NA study, sponsored by Mayo Clinic.
NCT05777161 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 162 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05777161, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of parent coached exposure therapy (PCET) and standard cognitive behavioral therapy (CBT) in treating childhood anxiety disorders and obsessive compulsive disorder (OCD).
Primary Outcome
Measured by the Clinical Global Impression Scale (GCI-S) rating of severity of psychopathology ranging from 1 (not at all ill) to 7 (extremely ill), with a score of 1 or 2 reflecting no to minimal symptoms
Interventions
- BEHAVIORAL Cognitive Behavior Therapy
- BEHAVIORAL Parent Coached Exposure Therapy - Individualized
- BEHAVIORAL Parent Coached Exposure Therapy - Group (removed from study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
What the finished NCT05777161 record still lists
NCT05777161 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavior Therapy is the first listed.
NCT05777161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05777161 about?
NCT05777161 is a clinical study titled "A Trial of Parent-coached Exposure Therapy for Children With Anxiety Disorders and OCD". The purpose of this study is to examine the effectiveness of parent coached exposure therapy (PCET) and standard cognitive behavioral therapy (CBT) in treating childhood anxiety disorders and obsessive compulsive disorder (OCD).
What is the current status of trial NCT05777161?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2020-11-11. Estimated completion is 2022-08-30.
What interventions are being tested in trial NCT05777161?
The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), Parent Coached Exposure Therapy - Individualized (BEHAVIORAL), Parent Coached Exposure Therapy - Group (removed from study) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05777161?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05777161's enrollment target sits among peer trials
162 627th of 2000 higher than 1,373 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI